SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-018930
Filing Date
2024-05-31
Accepted
2024-05-31 16:50:08
Documents
15
Period of Report
2024-05-30
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K nby20240531_8k.htm   iXBRL 8-K 28585
2 EXHIBIT 3.1 ex_681989.htm EX-3.1 15280
  Complete submission text file 0001437749-24-018930.txt   183556

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA nby-20240530.xsd EX-101.SCH 3401
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nby-20240530_def.xml EX-101.DEF 11801
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE nby-20240530_lab.xml EX-101.LAB 15848
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nby-20240530_pre.xml EX-101.PRE 12016
18 EXTRACTED XBRL INSTANCE DOCUMENT nby20240531_8k_htm.xml XML 2957
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

IRS No.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33678 | Film No.: 241010532
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)